BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Launches Educational Website to Raise Awareness of Treatment Options for Coronary Artery Disease


2/1/2011 6:28:08 AM

SAN DIEGO, Feb. 1, 2011 /PRNewswire/ -- The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) today announced the launch of DecisionsoftheHeart.com, a comprehensive resource to help patients with cardiovascular disease (CVD) better understand their condition and be more prepared, educated and active participants in their treatment decisions. The first phase of the website focuses on coronary artery disease (CAD), a type of CVD that affects approximately 17.6 million Americans and is the leading cause of death in the United States.

Once a patient is diagnosed with CAD, a treatment decision must be made quickly. Receiving the right treatment the first time means patients may live longer, have fewer heart attacks and need fewer repeat procedures. To aid patients in this decision, DecisionsoftheHeart.com provides tools and information such as:

  • A "Decision Tree" to help determine whether they may be a better candidate for bypass surgery or stenting;
  • A fact sheet that encourages patients to speak with a Cardiac Care Team of heart specialists before receiving a diagnostic angiogram and includes five key questions for patients to ask this team to ensure they are part of the decision-making process; and
  • A section about "beating heart" or OPCAB surgery, which has been shown to reduce the need for blood transfusions, neurologic complications and has enhanced outcomes in women.

"ISMICS was formed to organize and centralize medical breakthroughs and developments concerned with patient outcomes, techniques, and progressive development of less invasive forms of heart surgery," said Francis D. Ferdinand, M.D., Cardiovascular Surgeon and Treasurer of ISMICS. "As the treatment landscape for CAD evolves, we are pleased to provide this resource, which can educate and empower patients and help ISMICS further fulfill our mission to improve patient care."

Since the 1970s, the mainstay for treating moderate CAD has been stenting because of its short recovery time, while traditional, more invasive bypass surgery has been reserved for patients with severe disease. However, long-term data presented in September 2010 at an international medical conference put these practices into question. These data showed that patients with moderate or severe CAD who were treated with stents were 28 percent more likely to suffer a stroke or heart attack, 46 percent more likely to require additional procedures (e.g., more stents and eventually bypass surgery) and 22 percent more likely to die than CAD patients treated with bypass surgery.(1)

The "Decisions of the Heart" website will allow patients to benefit from a direct link to the ISMICS website for professionals so that the latest information, ISMICS Consensus Statements, and professional society guidelines become available in a straightforward, easy to understand format that patients and their families can use to better understand their treatment options. ISMICS will also develop a "Surgeon Locator" so that patients and their families can readily identify leading surgeons at the forefront of minimally invasive surgery from a trusted source.

For more information, please visit: DecisionsoftheHeart.com.

(1) Optimal revascularization strategy in patients with three-vessel disease and/or left main disease: The 3-year Outcomes of the SYNTAX Trial. Presented September 12, 2010, at the 24th European Association of Cardio-Thoracic Surgery (EACTS) Annual Meeting in Geneva, Switzerland.

About ISMICS

The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) was formed on May 31, 1997, by the participants of the World Congress of Minimally Invasive Cardiac Surgery at the Palais Des Congres in Paris, France, to organize and centralize the various surgical centers concerned with patient outcomes, techniques, and progressive development of less invasive forms of heart surgery. ISMICS has the only peer-reviewed Annual Scientific Meeting dedicated to the minimally invasive cardiothoracic surgery techniques and technology and is taking a leadership role on a global basis in shaping the direction of less invasive cardiac surgery.

SOURCE International Society for Minimally Invasive Cardiothoracic Surgery



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES